Sonoma Pharmaceuticals CFO Chad White resigns; Jerry Dvonch named interim CFO

Sonoma Pharmaceuticals, Inc.

Chad White resigned as CFO effective April 7, 2023; unvested options forfeited.
Board appointed Jerry Dvonch (former CFO, Sept 2020–Nov 2022) as interim CFO.
Dvonch to receive $250/hour plus $30,000 in restricted stock vesting July 15 and Aug 15, 2023.
Consulting agreement runs until filing of Q1 FY2024 10-Q (quarter ending June 30, 2023).
Dvonch's vested equity awards extended by one month per month of service under the agreement.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Chad White

Chief Financial Officer

SNOA · Sonoma Pharmaceuticals, Inc.

Effective: 2023-04-07
Successor: Jerry Dvonch
Filed: April 13, 2023, 7:59 PM ET

Effective April 7, 2023, Chad White resigned as our Chief Financial Officer, and our Board of Directors appointed Jerry Dvonch as our interim Chief Financial Officer.

Appointed (interim)

Jerry Dvonch

interim Chief Financial Officer

SNOA · Sonoma Pharmaceuticals, Inc.

Effective: 2023-04-07
Filed: April 13, 2023, 7:59 PM ET

Effective April 7, 2023, Chad White resigned as our Chief Financial Officer, and our Board of Directors appointed Jerry Dvonch as our interim Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Chad White resigned as Chief Financial Officer at Sonoma Pharmaceuticals, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

Effective April 7, 2023, Chad White resigned as our Chief Financial Officer, and our Board of Directors appointed Jerry Dvonch as our interim Chief Financial Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Jerry Dvonch was appointed as interim Chief Financial Officer at Sonoma Pharmaceuticals, Inc..

Action: appointed
Role: interim Chief Financial Officer

Exact text from the filing

Effective April 7, 2023, Chad White resigned as our Chief Financial Officer, and our Board of Directors appointed Jerry Dvonch as our interim Chief Financial Officer.

View on SEC.gov

Sonoma Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-23-002359

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.